MAP2 and ischemia: Concomitantly observed alterations in cellular NVU constituents thereby support the assumption that a critical affection of cell-stabilizing elements, such as MAP2 and NF-L, represents a key mechanism for cellular degeneration due to ischemia and might be considered a neuroprotective target.